VERRICA PHARMACEUTICALS INC. - COMMON STOCK

Verrica Pharmaceuticals Reports First Quarter 2022 Financial Results

09 مايو 2022 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Participation in the 21st Annual Needham Virtual Healthcare Conference

07 أبريل 2022 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

05 أبريل 2022 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results

02 مارس 2022 15:05:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Participation in the 42nd Annual Cowen Virtual Healthcare Conference

24 فبراير 2022 06:30:01 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Acceptance by FDA of NDA Resubmission for VP-102 for the Treatment of Molluscum Contagiosum

15 ديسمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Resubmission of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

29 نوفمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

18 نوفمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Reports Third Quarter 2021 Financial Results

12 نوفمبر 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Receives Complete Response Letter from the FDA identifying deficiencies at a facility of a Contract Manufacturer for its New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum

20 سبتمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Reports Second Quarter 2021 Financial Results

10 أغسطس 2021 06:30:01 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Appointment of Terry Kohler as Chief Financial Officer

09 يوليو 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Extension of FDA Review Period of its NDA for VP-102 for the Treatment of Molluscum Contagiosum

28 مايو 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Participation in the Jefferies Virtual Healthcare Conference

26 مايو 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Participation in the 2021 RBC Capital Markets Global Healthcare Conference

12 مايو 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Reports First Quarter 2021 Financial Results

07 مايو 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Pharmaceuticals Announces Participation in the 20th Annual Needham Virtual Healthcare Conference

06 أبريل 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Announces Election of Gary Goldenberg, MD, Verrica’s Chief Medical Officer, to Membership in the American Dermatological Association

29 مارس 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Verrica Announces Pricing of Public Offering of Common Stock

22 مارس 2021 20:31:20 بحسب Nasdaq GlobeNewswire

Verrica Announces Proposed Public Offering of Common Stock

22 مارس 2021 15:01:20 بحسب Nasdaq GlobeNewswire